Antimicrobial Peptide

What is an Antimicrobial Peptide?

Antimicrobial peptides (AMPs) are small proteins, typically 12-50 amino acids, that serve as the first line of defense against pathogens. They are produced by virtually all living organisms—from bacteria to humans—and can directly kill microorganisms through multiple mechanisms.

Key characteristics:

• Small size (12-50 amino acids typically)
• Usually cationic (positively charged)
• Amphipathic (both hydrophobic and hydrophilic regions)
• Broad-spectrum activity
• Multiple killing mechanisms

How AMPs Kill Pathogens

Primary mechanism: Membrane disruption

1. Attraction: Positively charged AMPs attracted to negatively charged bacterial membranes
2. Insertion: Hydrophobic regions insert into lipid bilayer
3. Disruption: Pore formation or membrane destabilization
4. Death: Cell contents leak out, pathogen dies

Additional mechanisms:

• Inhibit cell wall synthesis
• Block DNA/RNA synthesis
• Interfere with protein folding
• Disrupt intracellular targets

Why Bacteria Struggle to Resist AMPs

Unlike conventional antibiotics that target single pathways, AMPs present multiple challenges:

Factor	Conventional Antibiotic	AMP
Target	Single enzyme/pathway	Membrane + multiple targets
Mutation	Single mutation can confer resistance	Many mutations needed
Speed of resistance	Can be rapid	Generally slower
Cross-resistance	Common	Less common

Major Classes of Human AMPs

Class	Examples	Primary Location
Cathelicidins	LL-37	Neutrophils, epithelium
Defensins (α)	HNP-1, HNP-2	Neutrophils, Paneth cells
Defensins (β)	hBD-1, hBD-2	Epithelial surfaces
Histatins	Histatin 5	Saliva

LL-37: Key Human AMP

LL-37 is the only cathelicidin-derived AMP in humans:

Property	Value
Length	37 amino acids
Charge	+6 at physiological pH
Source	Neutrophils, macrophages, epithelial cells
Spectrum	Gram+, Gram-, fungi, some viruses

AMPs in Research

Several AMPs are being studied as potential therapeutics:

Peptide	Source	Research Focus
LL-37	Human cathelicidin	Infection, wound healing
Lactoferricin	Lactoferrin (milk)	Antimicrobial
Magainin	Frog skin	Antibiotic development
Defensins	Human neutrophils	Immune modulation

Beyond Antimicrobial Activity

AMPs have additional immunomodulatory functions:

• Chemotaxis (attract immune cells)
• Wound healing promotion
• Angiogenesis modulation
• Cytokine regulation
• Anti-inflammatory effects (context-dependent)

Challenges in AMP Drug Development

Challenge	Explanation
Stability	Degraded by proteases in blood
Toxicity	Can damage host cells at high concentrations
Cost	Expensive to manufacture
Delivery	Systemic delivery difficult
Spectrum	May be too broad or too narrow

Current Status

Approved AMP-derived drugs:

• Daptomycin (lipopeptide antibiotic)
• Polymyxins (last-resort antibiotics)

In development:

• Multiple AMPs in clinical trials
• Modified analogs with improved properties
• Combination approaches

Research Applications

AMPs are being explored for:

• Topical wound infections
• Catheter coatings
• Biofilm prevention
• Adjuncts to conventional antibiotics
• Anti-inflammatory conditions

---

This entry is for educational purposes only. AMPs discussed are research compounds unless otherwise noted.